Urinary Pharmacokinetics of 11-Nor-9-carboxy-Δ 9 -tetrahydrocannabinol after Controlled Oral Δ 9 -Tetrahydrocannabinol Administration

By Gustafson Richard A.  

Journal of Analytical Toxicology, Vol. 28, Iss. 3, 2004-04 ,pp. : 160-167

Oxford University Press

Access to resources Recommend Favorite

Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers

By Gorelick David A.   Goodwin Robert S.   Schwilke Eugene   Schwope David M.   Darwin William D.   Kelly Deanna L.   McMahon Robert P.   Liu Fang   Ortemann-Renon Catherine   Bonnet Denis   Huestis Marilyn A.  

Journal of Analytical Toxicology, Vol. 37, Iss. 1, 2013-01 ,pp. : 11-16

Oxford University Press

Access to resources Recommend Favorite

Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Δ 9 -Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

By Schwope David M.   Bosker Wendy M.   Ramaekers Johannes G.   Gorelick David A.   Huestis Marilyn A.  

Journal of Analytical Toxicology, Vol. 36, Iss. 6, 2012-07 ,pp. : 405-412

Oxford University Press

Access to resources Recommend Favorite

Correlation Between Pharmacological Effects and Plasma Cocaine Concentrations after Smoked Administration

By Jenkins Amanda J.   Keenan Robert M.   Henningfield Jack E.   Cone Edward J.  

Journal of Analytical Toxicology, Vol. 26, Iss. 7, 2002-10 ,pp. : 382-392

Oxford University Press

Access to resources Recommend Favorite

Implications of Plasma Δ 9 -Tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC Concentrations in Chronic Cannabis Smokers

By Karschner Erin L.  

Journal of Analytical Toxicology, Vol. 33, Iss. 8, 2009-10 ,pp. : 469-477

Oxford University Press

Access to resources Recommend Favorite